ArticleOncotarget2017

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Fangzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.